Home > Insider Trading > Filing (0000899243-21-015451)

Filing Details

Accession Number:: 0000899243-21-015451
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-08 21:28:42
Reporting Period:: 2021-04-06

Accepted Time:: 2021-04-08 21:28:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1832466	Alignment Healthcare Inc.	ALHC	()	NY

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1162870	Warburg Pincus Llc	C/O Warburg Pincus Llc 450 Lexington Aveue New York NY 10017	Yes	No	Yes	No
1540385	Wp Global Llc	C/O Warburg Pincus Llc 55 East 52Nd Street, 33Rd Floor New York NY 10017	Yes	No	Yes	No
1658396	Warburg Pincus Private Equity Xii, L.p.	C/O Warburg Pincus Llc 450 Lexinton Avenue New York NY 10017	Yes	No	Yes	No
1658398	Warburg Pincus Private Equity Xii-B, L.p.	C/O Warburg Pincus 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658400	Warburg Pincus Private Equity Xii-D, L.p.	C/O Warburg Pincus 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658404	Warburg Pincus Private Equity Xii-E, L.p.	C/O Warburg Pincus 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658412	Warburg Pincus Xii Partners, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658414	Wp Xii Partners, L.p.	C/O Warburg Pincus, Llc. 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1658787	Warburg Pincus Partners Ii, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No
1672765	Warburg Pincus Xii, L.p.	C/O Warburg Pincus Llc 450 Lexington Avenue New York NY 10017	Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Disposition	2021-04-06	716,624	$16.83	24,802,721	No	4	S	Indirect	See footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnotes

Footnotes

Represents 461,584 shares of Common Stock sold by Warburg Pincus Private Equity XII, L.P., a Delaware limited partnership ("WP XII"), 92,610 shares of Common Stock sold by Warburg Pincus Private Equity XII-B, L.P., a Delaware limited partnership ("WP XII-B"), 13,322 shares of Common Stock sold by Warburg Pincus Private Equity XII-D, L.P., a Delaware limited partnership ("WP XII-D"), and 76,034 share of Common Stock sold by Warburg Pincus Private Equity XII-E, L.P., a Delaware limited partnership ("WP XII-E"), 24,903 shares of Common Stock sold by WP XII Partners, L.P., a Delaware limited partnership ("WP XII Partners"), 48,171 shares of Common Stock sold by Warburg Pincus XII Partners, L.P., a Delaware limited partnership ("Warburg Pincus XII Partners") pursuant the partial exercise by the underwriters of their over-allotment option (the "Transaction") after the closing of Alignment Healthcare Inc.'s initial public offering, at a price of $16.83 (net of underwriting discount).
Reflects securities held directly by WP XII, WP XII-B, WP XII-D, WP XII-E, WP XII Partners, and Warburg Pincus XII Partners (together with WP XII, WP XII-B, WP XII-D, WP XII-E, and WP XII Partners, the "WP XII Funds") following the closing of the Transaction. Warburg Pincus XII, L.P., a Delaware limited partnership ("WP XII GP"), is the general partner of the WP XII Funds. WP Global LLC, a Delaware limited liability company ("WP Global"), is the general partner of WP XII GP. Warburg Pincus Partners II, L.P., a Delaware limited partnership ("WPP II"), is the managing member of WP Global. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WPP II.
(Continued Form Footnote 2 ) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WPP GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is a registered investment adviser and the manager of the WP XII Funds. Investment and voting decisions with respect to the shares held by the WP XII Funds are made by a committee comprised of three or more individuals and all members of such committee disclaim beneficial ownership of the shares.